LEXICON PHARMACEUTICALS, INC. (LXRX) › Shareholders' EquityLEXICON PHARMACEUTICALS, INC. (LXRX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $247.02M2011: $297.57M2012: $266.68M2013: $170.16M2014: $284.02M2015: $285.97M2016: $167.51M2017: $68.27M2018: -$26.41M2019: $117.10M2020: $156.37M2021: $113.59M2022: $117.12M2023: $93.11M2024: $145.95M2025: $107.54M$107.54M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$107.54M-26.3%2024$145.95M+56.8%2023$93.11M-20.5%2022$117.12M+3.1%2021$113.59M-27.4%2020$156.37M+33.5%2019$117.10M+543.5%2018-$26.41M-138.7%2017$68.27M-59.2%2016$167.51M-41.4%2015$285.97M+0.7%2014$284.02M+66.9%2013$170.16M-36.2%2012$266.68M-10.4%2011$297.57M+20.5%2010$247.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share